JVDI Advertisement
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riva, F
Right arrow Articles by Turin, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riva, F
Right arrow Articles by Turin, L
Journal of Veterinary Diagnostic Investigation, Vol 17, Issue 4, 385-388
Copyright © 2005 by American Association of Veterinary Laboratory Diagnosticians


Articles

A study of mutations in the c-kit gene of 32 dogs with mastocytoma

F Riva, S Brizzola, D Stefanello, S Crema, and L Turin

Dipartimento di Patologia Animale, Igiene e Sanita' Pubblica Veterinaria, Universita' degli Studi di Milano, Italy.

Mutations in the intracellular juxtamembrane domain of the c-kit gene in 32 dogs with different grades of histologically confirmed mastocytoma were studied. Transcript RNAs extracted from neoplastic tissue surgically collected from dogs of different breeds and from a negative control were reverse transcribed into complementary DNA and amplified by polymerase chain reaction. The region corresponding to the c-kit juxtamembrane domain was sequenced and compared with GenBank sequences. Two different types of mutations were identified within exon 11: a previously underscribed single-nucleotide substitution and a 6-bp deletion. The c-kit juxtamembrane domain sequences of all dogs were grouped in 3 clusters. No mutations were detected in tissues constitutively expressing c-kit (cerebellum and spleen), obtained from dogs not affected by mastocytoma (controls). All the substitutions were found in dogs bearing grade I or II mast cell tumors; the deletion was detected in 1 dog with grade II mastocytoma.


This article has been cited by other articles:


Home page
Vet PatholHome page
J. S. Munday, A. F. French, I. R. Gibson, and K. Gwynne
Widespread Mismatch Repair Protein Expression in Canine Cutaneous Mast Cell Tumors
Vet. Pathol., March 1, 2009; 46(2): 227 - 232.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
S. Letard, Y. Yang, K. Hanssens, F. Palmerini, P. S. Leventhal, S. Guery, A. Moussy, J.-P. Kinet, O. Hermine, and P. Dubreuil
Gain-of-Function Mutations in the Extracellular Domain of KIT Are Common in Canine Mast Cell Tumors
Mol. Cancer Res., July 1, 2008; 6(7): 1137 - 1145.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
J. D. Webster, V. Yuzbasiyan-Gurkan, R. A. Miller, J. B. Kaneene, and M. Kiupel
Cellular Proliferation in Canine Cutaneous Mast Cell Tumors: Associations with c-KIT and Its Role in Prognostication
Vet. Pathol., May 1, 2007; 44(3): 298 - 308.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association of Veterinary Laboratory Diagnosticians, Inc.